GR920100122A - Πολυσακχαρίτες οι οποίοι περιέχουν καρβοξύλιο με σταυροειδείς δεσμούς δια την πρόληψιν της προσφύσεως. - Google Patents
Πολυσακχαρίτες οι οποίοι περιέχουν καρβοξύλιο με σταυροειδείς δεσμούς δια την πρόληψιν της προσφύσεως.Info
- Publication number
- GR920100122A GR920100122A GR920100122A GR920100122A GR920100122A GR 920100122 A GR920100122 A GR 920100122A GR 920100122 A GR920100122 A GR 920100122A GR 920100122 A GR920100122 A GR 920100122A GR 920100122 A GR920100122 A GR 920100122A
- Authority
- GR
- Greece
- Prior art keywords
- adhension
- prevention
- ionically crosslinked
- containing polysaccharides
- crosslinked carboxyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/717—Celluloses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Μια μέθοδος ελαττώσεως μετεγχειρητικού σχηματισμού προσφύσεων δια τοπικής εφαρμογής ενός πολυσακχαρίτου που περιέχει καρβοξύλιο και έχει ιονικώς δημιουργήσει σταυροειδείς δεσμούς ή ενός φαρμακολογικώς παραδεκτού άλατος αυτού, π.χ. υαλουρονικού νατρίου το οποίον έχει δημιουργήσει σταυροειδείς δεσμούς με τριχλωριούχο σίδηρο εις μία θέση χειρουργικού τραύματος. ω
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68095591A | 1991-04-05 | 1991-04-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
GR920100122A true GR920100122A (el) | 1993-03-16 |
Family
ID=24733195
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR920100122A GR920100122A (el) | 1991-04-05 | 1992-03-26 | Πολυσακχαρίτες οι οποίοι περιέχουν καρβοξύλιο με σταυροειδείς δεσμούς δια την πρόληψιν της προσφύσεως. |
Country Status (10)
Country | Link |
---|---|
US (1) | US5532221A (el) |
EP (2) | EP0507604B1 (el) |
JP (1) | JP2702641B2 (el) |
AT (1) | ATE299706T1 (el) |
AU (1) | AU647905B2 (el) |
BR (1) | BR9201215A (el) |
CA (1) | CA2065111C (el) |
DE (1) | DE69233535T2 (el) |
ES (1) | ES2246490T3 (el) |
GR (1) | GR920100122A (el) |
Families Citing this family (86)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5629287A (en) * | 1991-01-18 | 1997-05-13 | University College London | Depot formulations |
US5610148A (en) * | 1991-01-18 | 1997-03-11 | University College London | Macroscopically oriented cell adhesion protein for wound treatment |
US5531716A (en) * | 1993-09-29 | 1996-07-02 | Hercules Incorporated | Medical devices subject to triggered disintegration |
US5419775A (en) * | 1994-01-18 | 1995-05-30 | Allergan, Inc. | Syringe flange adapter and method |
ITPD940054A1 (it) * | 1994-03-23 | 1995-09-23 | Fidia Advanced Biopolymers Srl | Polisaccaridi solfatati |
US5690961A (en) * | 1994-12-22 | 1997-11-25 | Hercules Incorporated | Acidic polysaccharides crosslinked with polycarboxylic acids and their uses |
WO1996039464A1 (en) * | 1995-06-06 | 1996-12-12 | C.R. Bard, Inc. | Process for the preparation of aqueous dispersions of particles of water-soluble polymers and the particles obtained |
US6214331B1 (en) | 1995-06-06 | 2001-04-10 | C. R. Bard, Inc. | Process for the preparation of aqueous dispersions of particles of water-soluble polymers and the particles obtained |
US5612321A (en) * | 1995-06-22 | 1997-03-18 | Hercules Incorporated | Antioxidant grafted polysaccharides |
AU718484B2 (en) * | 1995-08-29 | 2000-04-13 | Fidia Advanced Biopolymers S.R.L. | Biomaterials for preventing post-surgical adhesions comprised of hyaluronic acid derivatives |
SE505873C2 (sv) * | 1996-01-10 | 1997-10-20 | Moelnlycke Ab | Förfarande för framställning av absorberande material, absorberande material samt absorberande alster innehållande materialet ifråga |
US5688923A (en) * | 1996-02-15 | 1997-11-18 | Hercules Incorporated | Pectin fibers |
US5718862A (en) * | 1996-04-24 | 1998-02-17 | Hercules Incorporated | Secondary shaping of ionically crosslinked polymer compositions for medical devices |
US5684051A (en) * | 1996-04-24 | 1997-11-04 | Hercules Incorporated | Medical devices with improved elastic response |
US5820918A (en) * | 1996-07-11 | 1998-10-13 | Hercules Incorporated | Medical devices containing in-situ generated medical compounds |
US6060534A (en) | 1996-07-11 | 2000-05-09 | Scimed Life Systems, Inc. | Medical devices comprising ionically and non-ionically crosslinked polymer hydrogels having improved mechanical properties |
US6368356B1 (en) | 1996-07-11 | 2002-04-09 | Scimed Life Systems, Inc. | Medical devices comprising hydrogel polymers having improved mechanical properties |
ATE406176T1 (de) | 1996-12-06 | 2008-09-15 | Amgen Inc | Il-1-inhibitor in kombinationstherapie zur behandlung il-1-vermittelter krankheiten |
US5789571A (en) * | 1997-01-15 | 1998-08-04 | Biocoat Incorporated | Method of making free acids from polysaccharide salts |
US20050090662A1 (en) * | 1997-01-15 | 2005-04-28 | Beavers Ellington M. | Method of making free acids from polysaccharide salts |
US20050074495A1 (en) * | 1997-06-17 | 2005-04-07 | Fziomed, Inc. | Compositions of polyacids and methods for their use in reducing adhesions |
US5906997A (en) * | 1997-06-17 | 1999-05-25 | Fzio Med, Inc. | Bioresorbable compositions of carboxypolysaccharide polyether intermacromolecular complexes and methods for their use in reducing surgical adhesions |
US7192984B2 (en) * | 1997-06-17 | 2007-03-20 | Fziomed, Inc. | Compositions of polyacids and polyethers and methods for their use as dermal fillers |
US20040096422A1 (en) * | 1997-06-17 | 2004-05-20 | Schwartz Herbert E. | Compositions of polyacids and polyethers and methods for their use in reducing pain |
US6869938B1 (en) | 1997-06-17 | 2005-03-22 | Fziomed, Inc. | Compositions of polyacids and polyethers and methods for their use in reducing adhesions |
EP1114144A1 (en) | 1998-09-16 | 2001-07-11 | Oncopharmaceutical, Inc. | Treatment of oncologic tumors with an injectable formulation of a golgi apparatus disturbing agent |
AU3615700A (en) * | 1999-03-04 | 2000-09-21 | United States Surgical Corporation | Scar reduction |
US6472379B1 (en) | 1999-03-15 | 2002-10-29 | Trustees Of Boston University | Angiogenesis inhibition |
AU776564B2 (en) * | 1999-03-19 | 2004-09-16 | Genzyme Corporation | Surface modification of substrates |
US20040048021A1 (en) * | 1999-03-19 | 2004-03-11 | Wan Barbara Y. F. | Surface modification of substrates |
CA2366880C (en) * | 1999-04-02 | 2013-02-12 | Fziomed, Inc. | Compositions of polyacids and polyethers and methods for their use in reducing adhesions |
US7083777B1 (en) * | 1999-04-02 | 2006-08-01 | The Brigham And Women's Hospital, Inc. | Immunomodulating polymers |
KR20010010151A (ko) * | 1999-07-16 | 2001-02-05 | 김윤 | 수용성 알긴산염과 카르복시메틸 셀룰로오스를 주성분으로 하는 유착방지제 및 그의 제조방법 |
AU780363B2 (en) | 1999-07-28 | 2005-03-17 | United States Surgical Corporation | Hyaluronic acid anti-adhesion barrier |
US6566345B2 (en) | 2000-04-28 | 2003-05-20 | Fziomed, Inc. | Polyacid/polyalkylene oxide foams and gels and methods for their delivery |
US6638917B1 (en) | 2000-02-25 | 2003-10-28 | Scimed Life Systems, Inc. | Reducing adhesion |
CA2407235A1 (en) * | 2000-04-28 | 2001-11-08 | Fziomed, Inc. | Hemostatic compositions of polyacids and polyalkylene oxides and methods for their use |
JP2004513071A (ja) * | 2000-05-23 | 2004-04-30 | ザ・トラスティーズ・オブ・コロンビア・ユニバーシティ・イン・ザ・シティ・オブ・ニューヨーク | 肺の弾性繊維損傷に関連した呼吸器疾患の治療方法 |
WO2002028387A1 (en) | 2000-10-03 | 2002-04-11 | Oncopharmaceutical, Inc. | Inhibitors of angiogenesis and tumor growth for local and systemic administration |
SV2003000753A (es) | 2000-12-05 | 2003-06-16 | Brigham & Womens Hospital | Uso de polisacaridos zwitterionicos para la especifica modulacion del progreso inmunologico |
US6913765B2 (en) | 2001-03-21 | 2005-07-05 | Scimed Life Systems, Inc. | Controlling resorption of bioresorbable medical implant material |
AU2002320182B2 (en) * | 2001-06-29 | 2008-02-21 | Cook Biotech Incorporated | Porous sponge matrix medical devices and methods |
US7008979B2 (en) * | 2002-04-30 | 2006-03-07 | Hydromer, Inc. | Coating composition for multiple hydrophilic applications |
EP1507543A4 (en) * | 2002-05-09 | 2006-07-26 | Cambridgemed Inc | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF WOOD WITH BLOOD PLASMA OR SERUM |
US8137688B2 (en) * | 2003-01-10 | 2012-03-20 | The Cleveland Clinic Foundation | Hydroxyphenyl cross-linked macromolecular network and applications thereof |
US7465766B2 (en) * | 2004-01-08 | 2008-12-16 | The Cleveland Clinic Foundation | Hydroxyphenyl cross-linked macromolecular network and applications thereof |
US8138265B2 (en) * | 2003-01-10 | 2012-03-20 | The Cleveland Clinic Foundation | Hydroxyphenyl cross-linked macromolecular network and applications thereof |
US20040167480A1 (en) * | 2003-02-21 | 2004-08-26 | Advanced Medical Optics, Inc. | Administration of multiple viscoelastic solutions with a multi-compartment syringe |
JP2006522135A (ja) * | 2003-03-31 | 2006-09-28 | ザ ブライアム アンド ウィミンズ ホスピタル インコーポレーテッド | 喘息およびアレルギーの処置のための両性イオン免疫調節剤 |
CN100333804C (zh) * | 2003-04-18 | 2007-08-29 | 上海建华精细生物制品有限公司 | 透明质酸钠防粘连薄膜及其制备方法 |
US9066912B2 (en) | 2003-11-17 | 2015-06-30 | Ethicon, Inc. | Drug-enhanced adhesion prevention |
US8524213B2 (en) | 2003-12-30 | 2013-09-03 | Genzyme Corporation | Polymeric materials, their preparation and use |
US8277831B2 (en) * | 2004-02-17 | 2012-10-02 | Advanced Technologies And Regenerative Medicine, Llc. | Drug-enhanced adhesion prevention |
US20060040895A1 (en) * | 2004-08-19 | 2006-02-23 | Kipling Thacker | Aesthetic use of hyaluronan |
US7541396B2 (en) * | 2004-12-29 | 2009-06-02 | Weyerhaeuser Nr Company | Method for making carboxyalkyl cellulose |
US7230049B2 (en) * | 2004-12-29 | 2007-06-12 | Weyerhaeuser Co. | Method of crosslinking a carboxylated polymer using a triazine crosslinking activator |
US7393905B2 (en) * | 2004-12-29 | 2008-07-01 | Weyerhaeuser Company | Crosslinked mixed carboxylated polymer network |
US7241836B2 (en) * | 2004-12-29 | 2007-07-10 | Weyerhaeuser Co. | Method of crosslinking a mixture of carboxylated polymers using a triazine crosslinking activator |
US20060142478A1 (en) * | 2004-12-29 | 2006-06-29 | Mengkui Luo | Carboxyalkyl cellulose polymer network |
US20060142480A1 (en) * | 2004-12-29 | 2006-06-29 | Mengkui Luo | Method of making carboxyalkyl cellulose polymer network |
US20060142481A1 (en) * | 2004-12-29 | 2006-06-29 | Herriott Carole W | Method for making a mixed polymer network |
US20060142484A1 (en) * | 2004-12-29 | 2006-06-29 | Glasser Wolfgang G | Sulfoalkylated cellulose polymer network |
US20060142476A1 (en) * | 2004-12-29 | 2006-06-29 | Weerawarna S A | Crosslinked carboxylated polymer |
US20060142477A1 (en) * | 2004-12-29 | 2006-06-29 | Glasser Wolfgang G | Method for making sulfoalkylated cellulose polymer network |
US7300965B2 (en) | 2004-12-29 | 2007-11-27 | Weyerhaeuser Company | Mixed polymer network |
US20060142561A1 (en) * | 2004-12-29 | 2006-06-29 | Mengkui Luo | Carboxyalkyl cellulose |
CN100415310C (zh) * | 2005-03-04 | 2008-09-03 | 蒋婧 | 功能性术后隔离膜及其制备方法 |
US7323184B2 (en) * | 2005-08-22 | 2008-01-29 | Healagenics, Inc. | Compositions and methods for the treatment of wounds and the reduction of scar formation |
US8206726B2 (en) | 2006-02-06 | 2012-06-26 | The Brigham And Women's Hospital, Inc. | Zwitterionic polysaccharides for promotion of immune system maturation and health |
US8114159B2 (en) | 2006-11-20 | 2012-02-14 | Depuy Spine, Inc. | Anterior spinal vessel protector |
US8080260B2 (en) * | 2008-02-13 | 2011-12-20 | The Cleveland Clinic Foundation | Molecular enhancement of extracellular matrix and methods of use |
US8668863B2 (en) | 2008-02-26 | 2014-03-11 | Board Of Regents, The University Of Texas System | Dendritic macroporous hydrogels prepared by crystal templating |
WO2009135029A2 (en) * | 2008-04-30 | 2009-11-05 | The Cleveland Clinic Foundation | Compositions and methods to treat urinary incontinence |
KR101062068B1 (ko) | 2008-12-01 | 2011-09-02 | 포항공과대학교 산학협력단 | 유착방지용 조성물 |
ES2655592T3 (es) | 2010-03-29 | 2018-02-20 | Evonik Corporation | Composiciones y métodos para la retención mejorada de una composición farmacéutica en un sitio de administración local |
WO2012048283A1 (en) | 2010-10-08 | 2012-04-12 | Board Of Regents, The University Of Texas System | One-step processing of hydrogels for mechanically robust and chemically desired features |
US9095558B2 (en) | 2010-10-08 | 2015-08-04 | Board Of Regents, The University Of Texas System | Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications |
EP2731617A4 (en) | 2011-07-12 | 2015-07-01 | Brigham & Womens Hospital | LIPID-CONTAINING PSA COMPOSITIONS, METHODS OF ISOLATION AND METHODS OF USING SAME |
FR2983483B1 (fr) | 2011-12-02 | 2014-11-14 | Vivacy Lab | Procede de substitution et reticulation simultanees d'un polysaccharide via ses fonctions hydroxyles |
US11565027B2 (en) | 2012-12-11 | 2023-01-31 | Board Of Regents, The University Of Texas System | Hydrogel membrane for adhesion prevention |
JP6077663B2 (ja) | 2013-08-29 | 2017-02-08 | 大日精化工業株式会社 | 水不溶性成形体の製造方法及び水不溶性成形体 |
EP3337321A4 (en) | 2015-08-19 | 2019-07-17 | President and Fellows of Harvard College | LIPIDED PSA COMPOSITIONS AND METHOD |
CA2961868A1 (en) * | 2016-04-08 | 2017-10-08 | Johnson & Johnson Consumer Inc. | Topical compositions containing cross-linked glycosaminoglycans |
CA3030974A1 (en) | 2016-07-15 | 2018-01-18 | President And Fellows Of Harvard College | Glycolipid compositions and methods of use |
WO2018079812A1 (ja) * | 2016-10-31 | 2018-05-03 | キユーピー株式会社 | ゲル組成物及びその製造方法 |
WO2021201150A1 (ja) | 2020-03-31 | 2021-10-07 | 株式会社クレハ | 生体吸収性医療材料 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5436388A (en) * | 1977-08-26 | 1979-03-17 | Sumitomo Electric Ind Ltd | Porous polysaccharide and its preparation |
WO1986000912A1 (en) * | 1984-07-23 | 1986-02-13 | Pharmacia Ab | Gel for preventing adhesion between body tissues and process for its production |
JPS61207328A (ja) * | 1985-03-11 | 1986-09-13 | Taisho Pharmaceut Co Ltd | 腸溶性軟カプセル |
EP0312208A1 (en) * | 1987-09-18 | 1989-04-19 | Ethicon, Inc. | Gel formulations containing growth factors |
US4937254A (en) * | 1985-11-27 | 1990-06-26 | Ethicon, Inc. | Method for inhibiting post-surgical adhesion formation by the topical administration of non-steroidal anti-inflammatory drug |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4024073A (en) * | 1972-01-08 | 1977-05-17 | Toray Industries, Inc. | Hydrogel and production thereof |
US4141973A (en) * | 1975-10-17 | 1979-02-27 | Biotrics, Inc. | Ultrapure hyaluronic acid and the use thereof |
US4181718A (en) * | 1975-12-29 | 1980-01-01 | Mason Norbert S | Polyanion-stabilized aluminum hydrogels |
NL8003715A (nl) * | 1979-06-29 | 1980-12-31 | Union Carbide Corp | Verknoopte hydroxyethyl-carboxyethylcellulose- -bevattende waterige oplossingen. |
JPS5844711B2 (ja) * | 1979-07-04 | 1983-10-05 | 日東電工株式会社 | 水溶性感圧接着剤組成物 |
CS211876B1 (cs) * | 1980-04-30 | 1982-02-26 | Maxmilian Mozisek | Způsob výroby zesíťované karboxymetylcelulózy o vysoké sorpění kapacitě |
US4486335A (en) * | 1982-08-30 | 1984-12-04 | Hercules Incorporated | Carboxymethyl hydroxyethyl cellulose composition |
IN163192B (el) * | 1983-10-11 | 1988-08-20 | Fidia Spa | |
US4548847A (en) * | 1984-01-09 | 1985-10-22 | Kimberly-Clark Corporation | Delayed-swelling absorbent systems |
US4619995A (en) * | 1984-12-24 | 1986-10-28 | Nova Chem Limited | N,O-carboxymethyl chitosan and preparative method therefor |
SE8501022L (sv) * | 1985-03-01 | 1986-09-02 | Pharmacia Ab | Format alster och forfarande for dess framstellning |
CS264719B1 (cs) * | 1987-03-06 | 1989-09-12 | Galatik Antonin | Farmakologický přípravek na báze derivátu kyseliny hyaluronovej |
US4937270A (en) * | 1987-09-18 | 1990-06-26 | Genzyme Corporation | Water insoluble derivatives of hyaluronic acid |
IT1219587B (it) * | 1988-05-13 | 1990-05-18 | Fidia Farmaceutici | Polisaccaridi carbossiilici autoreticolati |
HU203372B (en) * | 1989-02-24 | 1991-07-29 | Richter Gedeon Vegyeszet | Process for producing hyaluronic associates and pharmaceutical compositions and cosmetics comprising such active ingredient |
ATE116555T1 (de) * | 1989-10-31 | 1995-01-15 | Howmedica | Chitinderivate enthaltende zusammensetzungen zur verhütung der adhäsion. |
US5093319A (en) * | 1989-10-31 | 1992-03-03 | Pfizer Hospital Products Group, Inc. | Use of derivatives of chitin soluble in aqueous solutions for preventing adhesions |
DE4115454A1 (de) * | 1991-05-11 | 1992-11-12 | Basf Ag | Eisen-(iii)-hyaluronate |
-
1992
- 1992-03-26 GR GR920100122A patent/GR920100122A/el not_active IP Right Cessation
- 1992-04-02 AU AU14015/92A patent/AU647905B2/en not_active Ceased
- 1992-04-03 CA CA002065111A patent/CA2065111C/en not_active Expired - Fee Related
- 1992-04-03 ES ES92302953T patent/ES2246490T3/es not_active Expired - Lifetime
- 1992-04-03 DE DE69233535T patent/DE69233535T2/de not_active Expired - Fee Related
- 1992-04-03 EP EP92302953A patent/EP0507604B1/en not_active Expired - Lifetime
- 1992-04-03 AT AT92302953T patent/ATE299706T1/de not_active IP Right Cessation
- 1992-04-03 EP EP05076407A patent/EP1593394A3/en not_active Withdrawn
- 1992-04-06 BR BR929201215A patent/BR9201215A/pt not_active Application Discontinuation
- 1992-04-06 JP JP4112371A patent/JP2702641B2/ja not_active Expired - Fee Related
-
1994
- 1994-02-04 US US08/192,336 patent/US5532221A/en not_active Expired - Lifetime
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5436388A (en) * | 1977-08-26 | 1979-03-17 | Sumitomo Electric Ind Ltd | Porous polysaccharide and its preparation |
WO1986000912A1 (en) * | 1984-07-23 | 1986-02-13 | Pharmacia Ab | Gel for preventing adhesion between body tissues and process for its production |
JPS61207328A (ja) * | 1985-03-11 | 1986-09-13 | Taisho Pharmaceut Co Ltd | 腸溶性軟カプセル |
US4937254A (en) * | 1985-11-27 | 1990-06-26 | Ethicon, Inc. | Method for inhibiting post-surgical adhesion formation by the topical administration of non-steroidal anti-inflammatory drug |
US4937254B1 (el) * | 1985-11-27 | 1992-08-11 | Ethicon Inc | |
EP0312208A1 (en) * | 1987-09-18 | 1989-04-19 | Ethicon, Inc. | Gel formulations containing growth factors |
Non-Patent Citations (3)
Title |
---|
DATABASE WPI Section Ch, Week 7917, Derwent Publications Ltd., London, GB; Class A11, AN 79-32582B & JP-A-54 036 388 (SUMITOMO ELEC. IND. KK) * |
DATABASE WPIL Section Ch, Week 8643, Derwent Publications Ltd., London, GB; Class A96, AN 86-282502 & JP-A-61 207 328 (TAISHO PHARMACEUT. KK) * |
STN INTERNATIONAL, KARLSRUHE. FILE 'CA', CHEMICAL ABSTRACTS. AN=CA100(6):36049v. M. MOZISEK, 'Crosslinked carboxymethyl cellulose with high sorption capacity ' * |
Also Published As
Publication number | Publication date |
---|---|
ES2246490T3 (es) | 2006-02-16 |
AU1401592A (en) | 1992-10-08 |
JP2702641B2 (ja) | 1998-01-21 |
ATE299706T1 (de) | 2005-08-15 |
US5532221A (en) | 1996-07-02 |
CA2065111C (en) | 1999-11-09 |
EP0507604B1 (en) | 2005-07-20 |
DE69233535D1 (de) | 2005-08-25 |
DE69233535T2 (de) | 2006-04-20 |
AU647905B2 (en) | 1994-03-31 |
EP1593394A2 (en) | 2005-11-09 |
EP0507604A2 (en) | 1992-10-07 |
EP0507604A3 (en) | 1993-10-06 |
BR9201215A (pt) | 1992-12-01 |
JPH05124968A (ja) | 1993-05-21 |
EP1593394A3 (en) | 2007-08-01 |
CA2065111A1 (en) | 1992-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR920100122A (el) | Πολυσακχαρίτες οι οποίοι περιέχουν καρβοξύλιο με σταυροειδείς δεσμούς δια την πρόληψιν της προσφύσεως. | |
WO1997007833A3 (en) | Biomaterials for preventing post-surgical adhesions comprised of hyaluronic acid derivatives | |
KR0179990B1 (en) | Tetrahydrofuran antifungals | |
DK0759760T3 (da) | Sårhelingsmiddel | |
ES2135541T3 (es) | Unguento para el tratamiento de heridas. | |
PL328412A1 (en) | Derivatives of benzamidine substituted with derivatives of amino acid and hydroxy acid as well as their application as antithrombotic agents | |
IS1794B (is) | Notkun á kítósan og fjölsykru í tengslum við sáragræðslu | |
IT1290814B1 (it) | Glicosaminoglicani aventi elevata attivita' antitrombotica | |
CO4840512A1 (es) | Derivados fluorados de la vitamina d3 posiciones farmaceuticas elaboradas a partir de estos deriva dos. | |
ES8707541A1 (es) | Un procedimiento para la preparacion de derivados de cefalosporina | |
DE69711024T2 (de) | Steuerung des heilungsprozesses | |
ATE299948T1 (de) | Tripeptidylpeptidase-inhibitoren | |
KR910007532A (ko) | 항트롬보 활성을 지닌 설페이트화 글리코 사미노글리큐로난 | |
AU621634B2 (en) | Glycerin derivative and its pharmacological use | |
SE9303612D0 (sv) | New use | |
DE3650221D1 (de) | Penemderivate. | |
AU559521B2 (en) | 5r,6s,8r-6-(1-hydroxyethyl)-2-(2-carbamoyloxyethylthio)- penem-3-carboxylic acid derivatives | |
ZA984433B (en) | Use of low-molecular-weight heparins for the prevention and treatment of cerebral oedemas | |
BG100531A (en) | Method for inhibition of photodecomposition of 3-substituted 2-oxindoles | |
CA2106695A1 (en) | Hyaluronic Acid and Forms to Prevent Arterial Restenosis | |
ES2034895A1 (es) | Composicion bebible que contiene por lo menos un dipeptido edulcorante, una sal de sacarina y un polisacarido hodrocoloidal. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ML | Lapse due to non-payment of fees |